Hypoxia-Selective Agents Derived from Quinoxaline 1,4-Di-N-oxides (original) (raw)
New quinoxaline 1,4-di- N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di- N-oxides
kamelia kamelia
Bioorganic & Medicinal Chemistry, 2006
View PDFchevron_right
New quinoxaline 1, 4-di-N-oxides: Anticancer and hypoxia-selective therapeutic agents
Magda Ismail
European Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Quinoxaline 1,4-dioxides as anticancer and hypoxia-selective drugs
Hala Gali-muhtasib
Oncology Reports, 2001
View PDFchevron_right
Tricyclic [1,2,4]Triazine 1,4-Dioxides As Hypoxia Selective Cytotoxins
Michael P Hay
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
Hypoxia-selective 3-alkyl-1, 2, 4-benzotriazine 1, 4-dioxide bioreductive drugs: Analogues of tirapazamine with improved in vivo activity
Michael P Hay
View PDFchevron_right
DNA-Targeted 1,2,4-Benzotriazine 1,4-Dioxides: Potent Analogues of the Hypoxia-Selective Cytotoxin Tirapazamine
Michael P Hay
Journal of Medicinal Chemistry, 2004
View PDFchevron_right
Selective Hypoxia‐Cytotoxin 7‐Fluoro‐2‐Aminophenazine 5,10‐Dioxide: Toward “Candidate‐to‐Drug” Stage in the Drug‐Development Pipeline
Romina Glisoni
ChemistrySelect, 2019
View PDFchevron_right
Esters of Quinoxaline 1ˏ4-Di-N-oxide with Cytotoxic Activity on Tumor Cell Lines Based on NCI-60 Panel
Syed Shoaib Ahmad Shah
View PDFchevron_right
DNA strand cleaving properties and hypoxia-selective cytotoxicity of 7-chloro-2-thienylcarbonyl-3-trifluoromethylquinoxaline 1,4-dioxide
Raquel García Villar
Bioorganic & Medicinal Chemistry, 2010
View PDFchevron_right
Hypoxia-selective 3-alkyl 1, 2, 4-benzotriazine 1, 4-dioxides: the influence of hydrogen bond donors on extravascular transport and antitumor activity
Michael P Hay
View PDFchevron_right
Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs
Mauricio Cabrera
Bioorganic & Medicinal Chemistry, 2009
View PDFchevron_right
Induction of Cell Death in Human A549 Cells Using 3-(Quinoxaline-3-yl) Prop-2-ynyl Methanosulphonate and 3-(Quinoxaline-3-yl) Prop-2-yn-1-ol
lerato raphoko
Molecules, 2019
View PDFchevron_right
Radicals from one-electron reduction of nitro compounds, aromatic N-oxides and quinones: the kinetic basis for hypoxia-selective, bioreductive drugs
Peter Wardman
Biochemical Society Symposia, 1995
View PDFchevron_right
Structure–activity relationship and role of oxygen in the potential antitumour activity of fluoroquinolones in human epithelial cancer cells
Luca Pretali
Journal of Photochemistry and Photobiology B: Biology, 2014
View PDFchevron_right
In-vitro Cytotoxicity Assay of Quinoxalines
Rahul Ingle
Journal of Current Pharma Research, 2017
View PDFchevron_right
Enzymatic single-electron reduction and aerobic cytotoxicity of tirapazamine and its 1-oxide and nor-oxide metabolites
Narimantas Čėnas
Chemija, 2018
View PDFchevron_right
Characterization of Radicals Formed Following Enzymatic Reduction of 3-Substituted Analogues of the Hypoxia-Selective Cytotoxin 3-Amino-1,2,4-Benzotriazine 1,4-Dioxide (Tirapazamine)
Michael P Hay
Journal of the American Chemical Society, 2010
View PDFchevron_right
The Radical Chemistry and Cytotoxicity of Bioreductive 3-Substituted Quinoxaline di-N-Oxides
Pooja Yadav
Chemical research in toxicology, 2016
View PDFchevron_right
Fused pyrazine mono-n-oxides as bioreductive drugs. II cytotoxicity in human cells and oncogenicity in a rodent transformation assay
Virginia Langmuir
International Journal of Radiation Oncology*Biology*Physics, 1996
View PDFchevron_right
Pharmacokinetic/pharmacodynamic model-guided identification of hypoxia-selective 1, 2, 4-benzotriazine 1, 4-dioxides with antitumor activity: the role of extravascular …
Michael P Hay
Journal of medicinal …, 2007
View PDFchevron_right
Synthesis and Biological Evaluation of New 2-Arylcarbonyl-3-trifluoromethylquinoxaline 1,4-Di- N -oxide Derivatives and Their Reduced Analogues
Silvia Pérez-silanes
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
2-(3-Aryl-2-propenoyl)-3-methylquinoxaline-1,4-dioxides: A novel cluster of tumor-specific cytotoxins which reverse multidrug resistance
Hiroshi Sakagami
Bioorganic & Medicinal Chemistry, 2009
View PDFchevron_right
Homologous recombination repair-dependent cytotoxicity of the benzotriazine di-N-oxide CEN-209: comparison with other hypoxia-activated prodrugs
Michael P Hay
View PDFchevron_right
Cytotoxicity evaluation of a new set of 2-aminobenzo[de]iso-quinoline-1,3-diones
Rashad Al-salahi, Mohamed Marzouk
International journal of molecular sciences, 2014
View PDFchevron_right
Phenazine 5,10-Dioxide Derivatives as Hypoxic Selective Cytotoxins: Part II. Structure-Activity Relationship Studies
Ana María Bruno
Medicinal Chemistry, 2006
View PDFchevron_right
Toxicity and Apoptosis Related Effects of Benzimidazo [3,2-α] Quinolinium Salts Upon Human Lymphoma Cells
Osvaldo Cox
The open medicinal chemistry journal, 2017
View PDFchevron_right
Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents
Ikhlas A. Sindi
Molecules, 2021
View PDFchevron_right
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells
Helen Seow, Krishnamurthy Shyam
Proceedings of the National Academy of Sciences of the United States of America, 2005
View PDFchevron_right
Enzyme-Activated, Hypoxia-Selective DNA Damage by 3-Amino-2-quinoxalinecarbonitrile 1,4-Di- N -oxide
Charles Barnes
Chemical Research in Toxicology, 2004
View PDFchevron_right
Synthesis and biological activity of benzothiazolo- and benzoxazolo[3,2-a]quinolinium salts
henry baez
Journal of Medicinal Chemistry, 1982
View PDFchevron_right